Copyright 2005 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
A 15-year-old boy with no known medical problems experienced vasovagal syncope several minutes after the third dose of hepatitis B vaccine. He fell backwards onto a concrete floor covered by a thin carpet, striking his occiput, and was momentarily unconscious. He briefly regained consciousness and complained of pain in the chest and arms. Then he reportedly had convulsions and went into cardiopulmonary arrest. Resuscitation attempts were unsuccessful. In a nearby emergency department, he was found to be in ventricular fibrillation, and attempts at defibrillation were unsuccessful. Autopsy revealed frontal lobe contusions, cerebral hemorrhage, cerebral edema, and no skull fracture. The death was ruled as accidental, and the medical examiner concluded that a vasovagal reaction had led to this injury. This death was first reported in the lay press, and then the events were reported to the Vaccine Adverse Event Reporting System (VAERS). The Food and Drug Administration (FDA) has previously described reports of syncope and unintentional injury after immunization,1 and there are now recommendations2 - 3 that patients be observed for 15 to 20 minutes after immunization.
Since the first of these recommendations was published in June of 2000,2 the FDA has received approximately 107 reports of syncope/presyncope and unintentional injury on the day of vaccination. Most (100) of these injuries reportedly occurred within 20 minutes of vaccination. One hundred five reports described falls, and 2 motor vehicle collisions were reported, including 1 that occurred 10 to 15 minutes after vaccination. Most (83) of the vaccinees were between 2 and 17 years old. Three reports described a history of syncope (with or without injury) after a previous vaccination.
In addition to the fatal event described above, 2 other syncope reports described severe head injuries. A 21-year-old man experienced intracerebral bleeding after falling backwards onto the floor 3 minutes after hepatitis B vaccine, tetanus toxoid, and diphtheria vaccine. He reportedly recovered without sequelae. An 18-year-old woman was in a fatal motor vehicle collision after she “passed out while driving her car” approximately 7 hours after meningococcal polysaccharide vaccine; the 7-hour interval between vaccination and the collision makes vaccine-related vasovagal syncope unlikely.
Sixty-five reports described moderate or minor injuries, most commonly contusions and lacerations of the head and extremities. Treatment included sutures, analgesics, and observation. The remaining reports (n=39) described falls without any fractures, contusions, or lacerations. Treatment was limited to observation and placement in a lying or sitting position.
At the time of the reported injury, nearly all (96) of these vaccinees were still in the clinic or other vaccination setting; 3 others were in the clinic parking lot. Although the vast majority of the reports of unintentional injury after vaccination do not describe any permanent sequelae, the continued occurrence of injuries and their potential preventability emphasize the need for vigilance in the immediate postvaccination period, with attention to the current recommendations.
Correspondence: Dr Woo, Center for Biologics Evaluation and Research, Food and Drug Administration, HFM-222, 1401 Rockville Pike, Rockville, MD 20852 (wooj@cber.fda.gov).
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Archives of Pediatrics and Adolescent Medicine editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
Users' Guides to the Medical Literature Example 2: Transient Loss of Consciousness
Users' Guides to the Medical Literature For example, in a sequence of studies of syncope, investigators required that the symptoms occur...
All results at JAMAevidence.com >
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.